Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
The Journal of Rheumatology
|
January 17, 2018
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis
Faekah Gohar, Janneke Anink, Halima Moncrieffe, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
M Emmy M Dolman, Evon Poon, Marli E Ebus, et al.
Molecular Cancer Therapeutics
|
April 14, 2021
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells
Lindy Vernooij, Laurel T Bate-Eya, Lindy K Alles, et al.
Journal of Medicinal Chemistry
|
November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in Neuroblastoma
Simon Krols, Muhammad Rishfi, Fien Martens, et al.
Frontiers in Oncology
|
October 14, 2022
Chromosome 11q loss and <i>MYCN</i> amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
Kaylee M Keller, Thomas F Eleveld, Linda Schild, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2021
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies
Kaylee M Keller, Sonja Krausert, Apurva Gopisetty, et al.
Translational Oncology
|
March 5, 2021
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia
Priscilla Wander, Susan T C J M Arentsen-Peters, Sandra S Pinhanҫos, et al.
Journal of Personalized Medicine
|
September 28, 2021
Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies
Waleed M Kholosy, Marc Derieppe, Femke van den Ham, et al.
Frontiers in Oncology
|
March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Thomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
The Journal of Rheumatology
|
January 17, 2018
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis
Faekah Gohar, Janneke Anink, Halima Moncrieffe, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
M Emmy M Dolman, Evon Poon, Marli E Ebus, et al.
Molecular Cancer Therapeutics
|
April 14, 2021
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells
Lindy Vernooij, Laurel T Bate-Eya, Lindy K Alles, et al.
Journal of Medicinal Chemistry
|
November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in Neuroblastoma
Simon Krols, Muhammad Rishfi, Fien Martens, et al.
Frontiers in Oncology
|
October 14, 2022
Chromosome 11q loss and <i>MYCN</i> amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
Kaylee M Keller, Thomas F Eleveld, Linda Schild, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2021
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies
Kaylee M Keller, Sonja Krausert, Apurva Gopisetty, et al.
Translational Oncology
|
March 5, 2021
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia
Priscilla Wander, Susan T C J M Arentsen-Peters, Sandra S Pinhanҫos, et al.
Journal of Personalized Medicine
|
September 28, 2021
Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies
Waleed M Kholosy, Marc Derieppe, Femke van den Ham, et al.
Frontiers in Oncology
|
March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Thomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Page
of 17